Health Equity and Outcomes Summit

Memo

Health equity is crucial to ensuring access for all individuals to access essential care - meanwhile pharmaceutical and biotechnology companies are pushing for necessary long-term changes to better meet the needs of vulnerable individuals and populations. With this being said, it is imperative for life science companies to discuss and educate both internally and externally regarding diversity, inclusion, and access to healthcare. Today, organizations across the biomedical research and healthcare ecosystems are mobilizing to help remove the obstacles to medical innovation, quality healthcare, and optimal health outcomes for underserved patients - making it important to address the broader health disparity challenges in the U.S. Attendees will learn practical solutions, share perspectives, and meet new industry and marketplace colleagues. This event can enhance these collective efforts and opportunities to collaborate internally as well to move health equity. Top 5 Reasons to Attend1. Leverage patient expertise in trial design and how to increase clinical trial diversity within your organization.2. Explore how to achieve health equity while creating strategic differentiation for brands.3. Recognize the importance of data and partnerships in advancing equity initiatives within your organization.4. Identify the importance of improving health equity across the life science industry.5. Building trust with patient advocacy groups, investigator networks, regulatory agencies, and industry partners to increase participation and retention of diverse patients in your clinical studies. URL:Tickets: https://go.evvnt.com/864452-1?pid=5569 Price:General Admission from: USD 695.0 Date and Time: On Tuesday December 07, 2021 at 8:00 am (ends Wednesday December 08, 2021 at 5:00 pm)